Advancing AI in Patient-Centered Blood Cancer Care with Meghan Gutierrez Lymphoma Research Foundation and Jennifer Branstetter BeOne Medicines TRANSCRIPT
Release Date: 03/23/2026
Shape-Shifting Device Extends Stroke Treatment to Smaller Brain Vessels with Ronen Eckhouse Rapid Medical TRANSCRIPT
Empowered Patient Podcast
Ronen Eckhouse, Co-Founder and CEO of Rapid Medical, identifies the limitations of current stroke treatments, which are primarily effective for large vessel occlusions. The Rapid Medical TIGERTRIEVER device is designed to safely and effectively treat strokes and remove clots in smaller vessels deeper in the brain. The unique adjustability of the device allows physicians to control the size and force during a procedure, allowing for precise and safer clot removal in complex anatomies. Ronen explains, "So the quicker or the less time there is between the stroke and the ability to...
info_outline
Shape-Shifting Device Extends Stroke Treatment to Smaller Brain Vessels with Ronen Eckhouse Rapid Medical
Empowered Patient Podcast
Ronen Eckhouse, Co-Founder and CEO of Rapid Medical, identifies the limitations of current stroke treatments, which are primarily effective for large vessel occlusions. The Rapid Medical TIGERTRIEVER device is designed to safely and effectively treat strokes and remove clots in smaller vessels deeper in the brain. The unique adjustability of the device allows physicians to control the size and force during a procedure, allowing for precise and safer clot removal in complex anatomies. Ronen explains, "So the quicker or the less time there is between the stroke and the ability to...
info_outline
Short RNA Therapy Targets Survival Genes in Treatment for Multiple Cancer Types with Robert Schickel NUAgo Therapeutics
Empowered Patient Podcast
Robert Schickel, Chief Executive Officer at NUAgo Therapeutics, is developing a cancer therapy using short RNAs to target and disrupt interconnected survival genes in cancer cells. The therapy has been shown to be non-toxic to healthy cells, which have high levels of microRNAs, whereas cancer cells downregulate microRNAs to become metastatic. This is a systems-biology therapeutic approach that targets the entire survival network of a cell, making it independent of specific mutations or pathways and potentially applicable to the vast majority of solid tumors. Robert explains, "NUAgo is a...
info_outline
Nuclear Oncology and Advanced Molecular Imaging Transforming Prostate Cancer Treatment with Dr. Babak Saboury United Theranostics TRANSCRIPT
Empowered Patient Podcast
Dr. Babak Saboury, Chief Scientific and Innovation Officer and Physician Founder of United Theranostics, discusses the emergence of nuclear oncology as the fourth pillar of cancer care. United Theranostics is combining advanced molecular imaging and radiopharmaceutical therapies to identify a cancer cell's unique fingerprint and then delivering targeted radiation, reducing side effects by sparing healthy cells. Molecular imaging can serve as a unifying map for guiding a collaborative, multimodal approach to treating a range of cancers. Babak explains, "I can just very quickly tell...
info_outline
Nuclear Oncology and Advanced Molecular Imaging Transforming Prostate Cancer Treatment with Dr. Babak Saboury United Theranostics
Empowered Patient Podcast
Dr. Babak Saboury, Chief Scientific and Innovation Officer and Physician Founder of United Theranostics, discusses the emergence of nuclear oncology as the fourth pillar of cancer care. United Theranostics is combining advanced molecular imaging and radiopharmaceutical therapies to identify a cancer cell's unique fingerprint and then delivering targeted radiation, reducing side effects by sparing healthy cells. Molecular imaging can serve as a unifying map for guiding a collaborative, multimodal approach to treating a range of cancers. Babak explains, "I can just very quickly tell...
info_outline
Local Drug Delivery Technology Transforming Pancreatic Cancer Treatment with Shaun Bagai RenovoRx TRANSCRIPT
Empowered Patient Podcast
Shaun Bagai, CEO of RenovoRx, has designed a drug-delivery platform to treat hard-to-reach chemo-resistant tumors such as pancreatic cancer by delivering chemotherapy directly to the tumor site. The RenovoCath device increases the drug concentration in the tumor while significantly reducing systemic toxicities and side effects. The technology is not intended to replace the traditional approach using systemic chemotherapy and radiation, but to achieve better results in tumors with low blood supply that prevent drugs from reaching their target in sufficient concentrations. Shaun explains,...
info_outline
Local Drug Delivery Technology Transforming Pancreatic Cancer Treatment with Shaun Bagai RenovoRx
Empowered Patient Podcast
Shaun Bagai, CEO of RenovoRx, has designed a drug-delivery platform to treat hard-to-reach chemo-resistant tumors such as pancreatic cancer by delivering chemotherapy directly to the tumor site. The RenovoCath device increases the drug concentration in the tumor while significantly reducing systemic toxicities and side effects. The technology is not intended to replace the traditional approach using systemic chemotherapy and radiation, but to achieve better results in tumors with low blood supply that prevent drugs from reaching their target in sufficient concentrations. Shaun explains,...
info_outline
How Patient Tech is Driving Innovation in Healthcare with Suzy Jackson TRANSCRIPT
Empowered Patient Podcast
Suzy Jackson, a digital health specialist focusing on Patient Tech, highlights the shift in the pharmaceutical industry from a provider-focused model to direct engagement with patients. Using AI to create a more consumer-like, personalized healthcare experience will benefit patients and inform researchers and providers about adherence to care and drug side effects. Patient Tech helps reach underserved populations and moves from providing information to a proactive environment, enabling action and more informed discussions with healthcare providers. Suzy explains, "So everything for me...
info_outline
How Patient Tech is Driving Innovation in Healthcare with Suzy Jackson
Empowered Patient Podcast
Suzy Jackson, a digital health specialist focusing on Patient Tech, highlights the shift in the pharmaceutical industry from a provider-focused model to direct engagement with patients. Using AI to create a more consumer-like, personalized healthcare experience will benefit patients and inform researchers and providers about adherence to care and drug side effects. Patient Tech helps reach underserved populations and moves from providing information to a proactive environment, enabling action and more informed discussions with healthcare providers. Suzy explains, "So everything for me...
info_outline
BCMA-Targeted Therapy Transforms Multiple Myeloma from Fatal to Chronic Disease with Dr. Robert Rifkin TRANSCRIPT
Empowered Patient Podcast
Dr. Robert Rifkin, medical oncologist and hematologist at the University of Colorado in Steamboat Springs. He was also a clinical investigator in the trial that led to the approval of BLENREP, a multiple myeloma drug from GSK. Multiple myeloma is the second most common blood cancer, and while the prognosis has dramatically improved, BLENREP is a novel treatment for patients whose disease has relapsed after other therapies. It is the first drug antibody conjugate approved for relapsed multiple myeloma, targeting the BCMA antigen, which is present on nearly all myeloma cells. Robert explains,...
info_outlineMeghan Gutierrez, CEO of the Lymphoma Research Foundation, and Jennifer Branstetter, the Executive Director, North America Corporate Affairs at BeOne Medicines, join me to discuss the growing use of AI in patient care with a specific focus on individuals with lymphoma and other blood cancers. Emphasis is on the necessity of a collaborative, patient-centric approach to developing AI tools, bringing together patient advocacy organizations, healthcare professionals, and pharma partners to provide accurate information to patients. The goal is to serve a diverse population by providing personalized, accessible information to help patients have more meaningful discussions with their healthcare providers, not to replace the clinician's role.
Jen explains, "We know that tens of millions of people are using AI tools in general, like ChatGPT, for health questions, including patients with blood cancers like chronic lymphocytic leukemia or CLL, they're all turning to the different AI tools that are out there. And from our perspective, we see this continuous growth of use, we want to make sure that the right healthcare information is getting fed into those AI resources and tools so that patients are getting the most accurate information possible."
Meg elaborates, "Many patients are using these AI tools to make sense of everything from their PET scans to their blood results, to some of the treatment language they receive in their clinician’s or doctor's office. And one of the things that I heard recently from a cancer patient who had uploaded his scans and some test results into an AI platform. And he called me incredibly concerned. He was very concerned about his prognosis and the limited treatment options that he believed were available to him."
"So when I pressed further, I found out that this AI platform was the only source of information that he had. So I became concerned when I recognized that the information he received was antiquated. So the treatment results and some of the information he was working from in this incredibly anxious and anxiety-provoking moment were 10 years old. And so in this case, antiquated information was as dangerous as inaccurate information. And both of these remain top concerns at the Lymphoma Research Foundation. And I think across our sector, as we see more and more patients using these tools and platforms to help educate them about their disease and their treatment options."
#LymphomaResearchFoundation #LRF #BeOneMedicines #LymphomaAwareness #AIinHealthcare #PatientAdvocacy #BloodCancer #HealthcareInnovation #PatientEmpowerment #PrecisionMedicine #CLL #HealthTech #CancerCare
